European Journal Of Haematology · 2007 · 71 citations · 12 references
Life SciencesGeneticsHematologyCytogeneticsHematopathologyHuman GeneticsChromosomal AbnormalitiesChromosomal DisordersClinical CytogeneticsGenetic DisordersMolecular CytogeneticsNumerical Chromosome AbnormalitiesClinical Cytogenetic DiagnosticsCytogenetic AberrationsCytogenetic AbnormalitiesCytogenetic Prognostic MarkersCytogenetics In Hematologic DiseaseJak2 MutationsJak2 V617f MutationNumerical Chromosomal Abnormalities
The prognostic significance of cytogenetic findings at diagnosis in polycythemia vera (PV) was investigated in a retrospective series of 137 patients. Cytogenetics were normal in 117 patients (85%) and displayed a -Y abnormality in five patients (7% of male patients), and other chromosomal abnormalities in 15 patients (11%). The most frequent cytogenetic anomalies were trisomy 8 (n = 4), trisomy 9 (n = 2), deletion 20q (n = 2) and chromosomal 1 abnormalities (n = 2). Parameters that were significantly associated with abnormal cytogenetics included age > or = 60 yr (P = 0.02), but not JAK2V617F allele burden, thrombosis, hemorrhage, leukemic/fibrotic transformation, or survival. We conclude that cytogenetic anomalies occur infrequently at PV diagnosis and do not confer an adverse outcome.
12
International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes
Peter L. Greenberg, Christopher Cox, Michelle M. LeBeau et al. · Blood · 1997 · 4.5K citations · Full text
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
Chloé James, Valérie Ugo, Jean‐Pierre Le Couedic et al. · Nature · 2005 · 3.5K citations
<i>JAK2</i> Exon 12 Mutations in Polycythemia Vera and Idiopathic Erythrocytosis
Linda M. Scott, Wei Tong, Ross L. Levine et al. · New England Journal of Medicine · 2007 · 1.2K citations · Full text